Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36

BACKGROUND: Up to now a malaria vaccine remains elusive. The Plasmodium falciparum serine repeat antigen-5 formulated with aluminum hydroxyl gel (BK-SE36) is a blood-stage malaria vaccine candidate that has undergone phase 1a trial in malaria-naive Japanese adults. We have now assessed the safety an...

Descripción completa

Detalles Bibliográficos
Autores principales: Palacpac, Nirianne Marie Q., Ntege, Edward, Yeka, Adoke, Balikagala, Betty, Suzuki, Nahoko, Shirai, Hiroki, Yagi, Masanori, Ito, Kazuya, Fukushima, Wakaba, Hirota, Yoshio, Nsereko, Christopher, Okada, Takuya, Kanoi, Bernard N., Tetsutani, Kohhei, Arisue, Nobuko, Itagaki, Sawako, Tougan, Takahiro, Ishii, Ken J., Ueda, Shigeharu, Egwang, Thomas G., Horii, Toshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665850/
https://www.ncbi.nlm.nih.gov/pubmed/23724021
http://dx.doi.org/10.1371/journal.pone.0064073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665850/
https://www.ncbi.nlm.nih.gov/pubmed/23724021
http://dx.doi.org/10.1371/journal.pone.0064073

Ejemplares similares